Connection
James Falko to Diabetic Angiopathies
This is a "connection" page, showing publications James Falko has written about Diabetic Angiopathies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.520 |
|
|
|
-
Falko JM, Moser RJ, Meis SB, Caulin-Glaser T. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia. Curr Diabetes Rev. 2005 May; 1(2):127-35.
Score: 0.212
-
Cottrell DA, Marshall BJ, Falko JM. Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome. Curr Opin Cardiol. 2003 Jul; 18(4):301-8.
Score: 0.187
-
Falko JM, Parr JH, Simpson RN, Wynn V. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med. 1987 Oct; 83(4):641-7.
Score: 0.063
-
Osei K, Holland G, Falko JM. Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med. 1986 Oct; 146(10):1973-7.
Score: 0.059